Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult

{
  "awards": [
    {
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Laboratory, optical and precision equipments (excl. glasses)",
              "id": "38000000",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UK"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-PPON-PBMJ-4568-WMPX",
          "name": "10x Genomics Inc"
        }
      ]
    }
  ],
  "buyer": {
    "id": "GB-COH-09928547",
    "name": "MEDICINES DISCOVERY CATAPULT LIMITED"
  },
  "contracts": [
    {
      "aboveThreshold": true,
      "awardID": "1",
      "dateSigned": "2025-12-18T00:00:00Z",
      "documents": [
        {
          "datePublished": "2026-01-05T14:03:50Z",
          "description": "Contract details notice on Find a Tender",
          "documentType": "contractNotice",
          "format": "text/html",
          "id": "000331-2026",
          "noticeType": "UK7",
          "url": "https://www.find-tender.service.gov.uk/Notice/000331-2026"
        }
      ],
      "hasRenewal": true,
      "id": "1",
      "noAgreedMetricsRationale": "not applicable",
      "period": {
        "endDate": "2026-12-17T23:59:59Z",
        "maxExtentDate": "2030-12-17T23:59:59Z",
        "startDate": "2025-12-18T00:00:00Z"
      },
      "renewal": {
        "description": "Maintenance"
      },
      "status": "active",
      "title": "Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult",
      "value": {
        "amount": 344000,
        "amountGross": 412800,
        "currency": "GBP"
      }
    }
  ],
  "date": "2026-01-05T14:03:50Z",
  "id": "000331-2026",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05f0dd",
  "parties": [
    {
      "additionalIdentifiers": [
        {
          "id": "PJPQ-6911-DQYY",
          "scheme": "GB-PPON"
        }
      ],
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Macclesfield",
        "postalCode": "SK10 4ZF",
        "region": "UKD62",
        "streetAddress": "Block 35g, Mereside Alderley Park"
      },
      "contactPoint": {
        "email": "procurement@md.catapult.org.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ]
      },
      "id": "GB-COH-09928547",
      "identifier": {
        "id": "09928547",
        "scheme": "GB-COH"
      },
      "name": "MEDICINES DISCOVERY CATAPULT LIMITED",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "US",
        "countryName": "United States",
        "locality": "Pleasanton",
        "postalCode": "CA 94588-3260",
        "region": "US",
        "streetAddress": "6230 Stoneridge Mall Road"
      },
      "contactPoint": {
        "email": "tenders@10xgenomics.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "sme",
        "shelteredWorkshop": false,
        "url": "https://www.10xgenomics.com/",
        "vcse": false
      },
      "id": "GB-PPON-PBMJ-4568-WMPX",
      "identifier": {
        "id": "PBMJ-4568-WMPX",
        "scheme": "GB-PPON"
      },
      "name": "10x Genomics Inc",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics. The purchase of the equipment will be at a value of \u00a3220,000, with the possibility for four twelve month extension of warranty periods.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "ocds-h6vhtk-05f0dd",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Single supplier - technical reasons\nMedicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics, on the basis that no reasonable alternative or substitute exists which meets the specific technical and operational requirements of the organisation.\nIndependent comparative studies have demonstrated that alternative platforms currently on the market exhibit significantly higher levels of background noise, reducing data quality in single cell spatial analysis. MDC has verified these performance results and determined that the Xenium system is uniquely capable of delivering the sensitivity and precision required for our research and service activities.\nBeyond this the Xenium platform also offers operational advantages. It enables the use of panels with a low minimum run size, which aligns closely with the typical experimental scale within MDC. Competing systems require substantially higher minimum slide numbers, making them unsuitable and leading to inefficient use of resources.\nIn addition, acquiring the Xenium system will strengthen MDC\u0027s national role by providing UK drug discovery organisations access to a capability that is not currently available within any UK based CRO. This avoids duplication with existing commercial provider and ensures MDC can offer new and complementary capabilities to the wider life sciences community.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "title": "Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult"
  }
}